Telangana DCA seizes overpriced anti-fungal medicine Itwage-200 Capsules at Hyderabad

Written By : Ruchika Sharma |Medically Reviewed By : Dr. Kamal Kant Kohli Published On 2024-11-28T17:53:16+05:30 | Updated On 28 Nov 2024 5:53 PM IST

Telangana: Drugs Control Administration, Telangana officials seized overpriced anti-fungal medicine 'Itwage-200 Capsules' (Itraconazole Capsules 200 mg) at a medical shop located in Amberpet, Hyderabad. The MRP indicated is very high compared to the Ceiling Price fixed for the product by the Central Government.

The product Itraconazole Capsules 200 mg sold under brand name ‘Itwage-200 Capsules’ is under price control as per Drugs (Prices Control) Order, 2013 and the price of product shall be in accordance with the ‘Ceiling Price’ fixed by National Pharmaceutical Pricing Authority (NPPA), Government of India. The product ‘Itwage-200 Capsules’ (Itraconazole Capsules 200 mg) of Batch No.: TC-710, Mfg. Dt.: 12/2023, Exp. Dt.: 11/2025, Manufactured by: Tosc International Pvt. Ltd., Plot. No. 47, Sector-3, SIDCUL, Pantnagar-263153, Uttarakhand and Marketed by: Skinocean Pharmaceuticals, Chennai, Tamilnadu bears MRP as Rs. 299/- for 10 capsules, on the label of the product which is a violation of Drugs (Prices Control) Order, 2013.

The Ceiling price fixed by the Central Government including Wholesale Price Index (WPI) for the product “Itraconazole Capsules 200 mg” is Rs. 22.12 for one capsule (Ceiling Price) i.e. Rs. 221.2 for 10 capsules. Hence Maximum Retail Price (MRP) i.e. including GST 12 % should not be more than Rs. 247.74 for 10 capsules (MRP=Ceiling Price+GST).

Read also: Raid: Telangana DCA Seizes Cefuroxime, Dexamethasone, Other Antibiotics, Steroids from Unlicensed Clinic

The firm overpriced the product. Firm charged excess of Rs. 51.25/- for 10 capsules which is a violation of Drugs (Prices Control) Order, 2013. Sri. V. Ajay, Drugs Inspector, Amberpet carried out the raid. Further investigation shall be carried out and action shall be taken as per the law against all the offenders.

telangana Drugs Control Administrationfungal medicineItwage 200 Capsulesitraconazoleraid

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Dr. Kamal Kant Kohli

Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751